l carnitine prostate cancer Frontiers Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9)
Acetyl L Carnitine downregulates invasion (CXCR4 CXCL12, MMP 9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies Journal of Experimental & Clinical Cancer Research Springer Clinical Significance of Carnitine in the Treatment of Cancer: From Traffic to the Regulation PMC Lipid Metabolism Modulatory Cisplatin Prodrug Sensitizes Resistant Prostate Cancer toward Androgen Deprivation Therapy ACS Pharmacology & Translational Science Acetyl l carnitine is an anti angiogenic agent targeting the VEGFR2 and CXCR4 pathways ScienceDirect Targeting Prostate Cancer Metabolism Through Transcriptional and Epigenetic Modulation: A Multi Target Approach to Therapeutic Innovation
Pay in 4 interest-free payments of $6.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15




